findmyKOL
Clinical trialNCT05950464RecruitingPhase 1Interventional

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

SponsorNational Cancer Institute (NCI)Enrollment65Recurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell AdenocarcinomaRecurrent Endometrial Endometrioid AdenocarcinomaRecurrent Endometrial Low Grade Endometrioid AdenocarcinomaRecurrent Ovarian Clear Cell AdenocarcinomaRecurrent Ovarian Endometrioid Adenocarcinoma+3 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Augusta University Medical Center

    Augusta, Georgia, United States

    Suspended
  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois, United States

    Katherine C. Kurnit
    Recruiting
  • University of Iowa/holden Comprehensive Cancer Center

    Iowa City, Iowa, United States

    David P. Bender
    Recruiting
  • Wayne State University/karmanos Cancer Institute

    Detroit, Michigan, United States

    Suspended
  • University of New Mexico Cancer Center

    Albuquerque, New Mexico, United States

    Carolyn Y. Muller
    Recruiting
  • Case Western Reserve University

    Cleveland, Ohio, United States

    Active, not recruiting
  • Cleveland Clinic Foundation

    Cleveland, Ohio, United States

    Peter G. Rose
    Recruiting
  • Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, United States

    John L. Hays
    Recruiting
  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma, United States

    Lauren E. Dockery
    Recruiting
  • Nrg Oncology

    Philadelphia, Pennsylvania, United States

    Fiona Simpkins
    Recruiting
  • Thomas Jefferson University Hospital

    Philadelphia, Pennsylvania, United States

    Mitchell I. Edelson
    Recruiting
  • University of Pennsylvania/abramson Cancer Center

    Philadelphia, Pennsylvania, United States

    Fiona Simpkins
    Recruiting
  • Women and Infants Hospital

    Providence, Rhode Island, United States

    Cara A. Mathews
    Recruiting
  • Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

    William H. Bradley
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Dec 2023
Primary completion
30 Jun 2027
Completion
30 Jun 2027
Last update posted
9 Jul 2026
Registered enrollment
65
Registry id
NCT05950464

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.